Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Sep 2025.
- Notable investors include Paladin Capital Group, General Inception, Skysong Innovations, Vertical Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for CryoVeritas
- ·The full record, as it builds
Funding rounds
No funding rounds for CryoVeritas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CryoVeritas
Developer of a cryogenic electron microscopy technology intended to study the structure of biological molecules at the atomic level. The company provides services related to cryogenic electron microscopy, including sample preparation, data acquisition, and image processing, and can prepare a wide variety of biological samples for cryogenic electron microscopy, including proteins, viruses, and cells, enabling scientists to make important discoveries in a variety of fields, including medicine, biotechnology, and materials science.
- Sector
- Healthcare
- HQ
- Tempe, AZ, United States
- Founded
- 2022
- Employees
- 2
- Website
- cryoveritas.com/
- Ownership
- Privately Held (backing)
CryoVeritas doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CryoVeritas shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CryoVeritas in its N-PORT filings yet. We sweep new filings monthly.